Basic information Safety Related Supplier

Fosaprepitant dimeglumine

Basic information Safety Related Supplier
Fosaprepitant dimeglumine Basic information
Fosaprepitant dimeglumine Usage And Synthesis
  • DescriptionOne of the most debilitating side effects of cancer treatment is CINV. Although concomitant anti-emetic agents have been prevalent for the past two decades, 50 60% of patients are still plagued by CINV. To meet this need, fosaprepitant dimeglumine has been launched as a water-soluble, phosphoryl pro-drug of aprepitant for intravenous applications. This pro-drug is rapidly converted to aprepitant in vivo, which has a high affinity for the NK-1 receptor (IC50= 90 50 pM for the displacement of [125I]-substance P from hNK-1 expressed in CHO cells); antagonism 606 Shridhar Hegde and Michelle Schmidt of NK-1 prevents binding of the endogenous substance P that is known to induce vomiting. Fosaprepitant is prepared by the regioselective phosphorylation of aprepitant with dibenzylphosphoryl chloride followed by catalytic hydrogenolysis in the presence of N-methyl-Dglucamine. It is approved for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly and moderately emetogenic cancer chemotherapy.
  • OriginatorMerck (United States)
  • UsesFosaprepitant is a water-soluble phosphoryl prodrug for Aprepitant which is a NK1 antagonist
  • DefinitionChEBI: An organoammonium salt obtained by reaction of fosaprepitant with two equivalents of 1-deoxy-1-(methylamino)-D-glucitol. A substance P/neurokinin 1 (NK1) receptor antagonist. Aprepitant is a selective high-affinity antagonist of human subs ance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting and postoperative nausea and vomiting
  • brand nameIvEmend
Fosaprepitant dimeglumine(265121-04-8)Related Product Information
Fosaprepitant dimeglumineSupplierMore
  • Company Name:Viwit Pharmaceutical Co., Ltd. Gold
  • Tel:15063270987 0632-2980981-
  • Email:service.china3@viwit.com
  •  
  • Company Name:Shanghai Huilun Life Science&Technology Co.Ltd. Gold
  • Tel:021-34304206
  • Email:lmxqi0626@163.com
  •  
  • Company Name:Beijing Autumn Biomedical Technology Co., Ltd Gold
  • Tel:010-80828512 18001163873
  • Email:wangcb2001@163.com
  •  
  • Company Name:Emei shan Hongsheng Pharmaceutical Co., LTD Gold
  • Tel:18784599437 0833-5590788-
  • Email:sales@hongshengpharm.com;sales@hongshengpharm.com;sales@hongshengpharm.com
  •  
  • Company Name:Zhejiang Warrant Pharmaceutical Co.,Ltd. Gold
  • Tel:+86512-85180611
  • Email:felix@lanxite.com
  •